Literature DB >> 12819906

A combination of high concentrations of serum triglyceride and non-high-density-lipoprotein-cholesterol is a risk factor for cardiovascular disease in subjects with abnormal glucose metabolism--The Hoorn Study.

G Bos1, J M Dekker, G Nijpels, F de Vegt, M Diamant, C D A Stehouwer, L M Bouter, R J Heine.   

Abstract

AIMS/HYPOTHESIS: Type 2 diabetes is not only associated with hyperglycaemia, but also with disorders of lipid metabolism. The aim of this study was to investigate the association of triglyceride and non-HDL-cholesterol concentrations with cardiovascular disease in subjects with normal and abnormal glucose metabolism.
METHODS: Subjects were 869 men and 948 women aged 50 to 75 who participated in the Hoorn Study, a population-based cohort study that started in 1989. Glucose metabolism was determined by a 75 g OGTT. High fasting triglyceride and non-HDL-cholesterol concentrations were defined as above the median of the study population.
RESULTS: After 10 years of follow-up, the age- and sex-adjusted hazard ratios for cardiovascular disease were 1.35 (1.11-1.64) and 1.71 (1.40-2.08) for high triglycerides and high non-HDL-cholesterol, respectively, after mutual adjustment. After stratification for glucose metabolism status, the hazard ratios for cardiovascular disease for non-HDL-cholesterol were 1.70 (1.31-2.21) in normal glucose metabolism and 1.56 (1.12-2.18) in abnormal glucose metabolism. Triglycerides were not a risk factor in subjects with normal glucose metabolism, with a hazard ratio of 0.94 (0.73-1.22), but in subjects with abnormal glucose metabolism, the hazard ratio for cardiovascular disease was 1.54 (1.07-2.22). In subjects with abnormal glucose metabolism, the hazard ratio for the combined presence of high triglycerides and non-HDL-cholesterol was 2.12 (1.35-3.34).
CONCLUSION: Our data suggest that in people with abnormal glucose metabolism, but not in those with normal glucose metabolism, high triglyceride concentration could be associated with the risk of cardiovascular disease, particularly in people with high non-HDL-cholesterol.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12819906     DOI: 10.1007/s00125-003-1141-5

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

1.  Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target.

Authors:  S M Grundy
Journal:  Arch Intern Med       Date:  2001-06-11

Review 2.  Management of dyslipidemia in NIDDM.

Authors:  A Garg; S M Grundy
Journal:  Diabetes Care       Date:  1990-02       Impact factor: 19.112

Review 3.  Cholesterol in the prediction of atherosclerotic disease. New perspectives based on the Framingham study.

Authors:  W B Kannel; W P Castelli; T Gordon
Journal:  Ann Intern Med       Date:  1979-01       Impact factor: 25.391

4.  Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP).

Authors:  P H Frost; B R Davis; A J Burlando; J D Curb; G P Guthrie; J L Isaacsohn; S Wassertheil-Smoller; A C Wilson; J Stamler
Journal:  Circulation       Date:  1996-11-15       Impact factor: 29.690

Review 5.  Hypertriglyceridemia: changes in the plasma lipoproteins associated with an increased risk of cardiovascular disease.

Authors:  H B Brewer
Journal:  Am J Cardiol       Date:  1999-05-13       Impact factor: 2.778

Review 6.  Management of primary hyperlipidemia.

Authors:  R J Havel; E Rapaport
Journal:  N Engl J Med       Date:  1995-06-01       Impact factor: 91.245

7.  Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study.

Authors:  J R McNamara; P K Shah; K Nakajima; L A Cupples; P W Wilson; J M Ordovas; E J Schaefer
Journal:  Atherosclerosis       Date:  2001-01       Impact factor: 5.162

8.  The emergence of triglycerides as a significant independent risk factor in coronary artery disease.

Authors:  G Assmann; H Schulte; H Funke; A von Eckardstein
Journal:  Eur Heart J       Date:  1998-10       Impact factor: 29.983

9.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation.

Authors:  K G Alberti; P Z Zimmet
Journal:  Diabet Med       Date:  1998-07       Impact factor: 4.359

10.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04
View more
  12 in total

Review 1.  Prandial glucose regulation in the glucose triad: emerging evidence and insights.

Authors:  Paul Beisswenger; Robert J Heine; Lawrence A Leiter; Alan Moses; Jaakko Tuomilehto
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

Review 2.  The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.

Authors:  Ai-Hua Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

Review 3.  Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients.

Authors:  Szu-chi Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

4.  Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes.

Authors:  Anne Hiukka; Jamila Fruchart-Najib; Eeva Leinonen; Hannele Hilden; Jean-Charles Fruchart; Marja-Riitta Taskinen
Journal:  Diabetologia       Date:  2005-04-30       Impact factor: 10.122

5.  Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes.

Authors:  M B Schulze; I Shai; J E Manson; T Li; N Rifai; R Jiang; F B Hu
Journal:  Diabetologia       Date:  2004-12-15       Impact factor: 10.122

Review 6.  Postprandial dysmetabolism and cardiovascular disease in type 2 diabetes.

Authors:  M E Tushuizen; M Diamant; R J Heine
Journal:  Postgrad Med J       Date:  2005-01       Impact factor: 2.401

7.  Comparison of various lipid variables as predictors of coronary heart disease in Japanese men and women with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study.

Authors:  Hirohito Sone; Sachiko Tanaka; Shiro Tanaka; Satoshi Iimuro; Shun Ishibashi; Shinichi Oikawa; Hitoshi Shimano; Shigehiro Katayama; Yasuo Ohashi; Yasuo Akanuma; Nobuhiro Yamada
Journal:  Diabetes Care       Date:  2012-02-14       Impact factor: 19.112

8.  Impact of admission triglyceride for early outcome in diabetic patients with stable coronary artery disease.

Authors:  Xiao-Lin Li; Li-Feng Hong; Song-Hui Luo; Yuan-Lin Guo; Cheng-Gang Zhu; Jing Sun; Qian Dong; Ping Qing; Rui-Xia Xu; Jun Liu; Sha Li; Na-Qiong Wu; Geng Liu; Jian-Jun Li
Journal:  Lipids Health Dis       Date:  2014-04-27       Impact factor: 3.876

Review 9.  The independent relationship between triglycerides and coronary heart disease.

Authors:  Alan Morrison; John E Hokanson
Journal:  Vasc Health Risk Manag       Date:  2009-04-08

Review 10.  Implications of the obesity epidemic for lipid-lowering therapy: non-HDL cholesterol should replace LDL cholesterol as the primary therapeutic target.

Authors:  Michel R Hoenig
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.